Zinbryta (daclimizumab) "safety action" in EU

[agate]

People aren't keen on taking an MS drug if it has serious side effects, understandably, and now another of them, Zinbryta (daclimizumab), is getting bad marks, according to this article in FiercePharma (July 10):

Only registered and activated users can see links., Click Here To Register...

[Sunshine]

And yet the cheap and safe alpha Lipoic acid did well compared to Ocrevus. Stockpile it now before big pharma buys it and jacks up the price.

[Virginia]

Reminds me, I forgot to get more of the ALA since I threw my last out. I am planning to do that.

[Sunshine]

600 mg twice per day